Stuart S. Martin, PhD
Drs. Angela and Harry Brodie Professor of Translational Cancer Research
Professor of Pharmacology and Physiology
Interim Chair, Department of Pharmacology and Physiology
Deputy Director of the Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC)
University of Maryland School of Medicine
TetherChip Optimization for Precision Medicine Applications
For more information about this technology, please contact the UM Ventures, Baltimore team.
Bio
I received my PhD from the University of California-San Diego in Biomedical Sciences, a program that combined molecular cell biology with pharmacology and physiology. As a graduate student with Dr. Jerry Olefsky, I focused on insulin-stimulated rearrangement of the actin cytoskeleton, and demonstrated that PI3-Kinase was sufficient to induce actin membrane ruffling and stress fiber breakdown. After graduating in 1998, I moved to Dr. Phil Leder's lab at Harvard Medical School to study how cell shape and the actin cytoskeleton can influence cell survival. My postdoctoral training allowed me to combine functional genomic tissue culture systems with mouse models of breast cancer. In 2004, I joined the Department of Physiology at the University of Maryland School of Medicine as an Assistant Professor. I am currently a Professor in the Department of Pharmacology. I also serve as co-leader of Hormone-Related Cancers (HRC), a group of 45 investigator labs that are focused on breast, prostate and ovarian cancers within the Marlene and Stewart Greenebaum Comprehensive Cancer Center. In 2020, I was honored to be awarded the Drs. Angela and Harry Brodie Endowed Professorship in Translational Cancer Research.